Knight Therapeutics Inc. (TSX: GUD)

Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	62.84	58.76	71.68	85.96	229.59	169.27
Short-Term Investments	112.21	95.66	85.83	63.54	147.32	238.49
Trading Asset Securities	17.03	15.45	28.11	10.65	29.15	6.54
Cash & Short-Term Investments	192.07	169.87	185.61	160.16	406.05	414.3
Cash Growth	8.05%	-8.48%	15.89%	-60.56%	-1.99%	-40.49%
Accounts Receivable	85.96	88.72	94.89	55.39	62.52	85.85
Other Receivables	9.58	9.51	13.68	12.03	19.53	25.89
Total Receivables	95.54	98.23	114	69.96	87.15	125.17
Inventory	95.4	91.83	92.49	72.4	56.51	70.87
Prepaid Expenses	5.25	4.88	3.34	2.17	2.21	3.31
Restricted Cash	-	-	-	-	-	5
Other Current Assets	0.18	0.3	0.18	0.29	0.18	2.88
Total Current Assets	388.45	365.12	395.62	304.97	552.1	621.52
Gross Property, Plant & Equipment	-	39.46	56.06	41	30.73	30
Accumulated Depreciation	-	-21.6	-33.42	-11.07	-4.57	-0.96
Net Property, Plant & Equipment	21.55	17.86	22.63	29.94	26.16	29.05
Long-Term Investments	102.06	116.36	152.33	174.23	169.79	241.13
Goodwill	85.51	79.84	82.27	75.4	77.73	88.26
Other Intangible Assets	290.73	289.96	338.78	350.3	156.55	173.37
Long-Term Accounts Receivable	-	-	-	-	-	4.72
Long-Term Deferred Tax Assets	23.85	19.39	9.31	2.05	2.43	3.99
Other Long-Term Assets	52.3	53.3	50.13	51.28	51.18	126.13
Total Assets	968.21	945.49	1,055	991.89	1,040	1,305
Accounts Payable	86.03	85.37	106.06	65.31	44.51	72.83
Accrued Expenses	-	-	-	-	-	21.58
Short-Term Debt	-	0.61	1.61	9.19	10.11	-
Current Portion of Long-Term Debt	19.32	17.24	16.06	17.48	41.66	50.56
Current Portion of Leases	2.78	1.73	2.58	1.61	1.88	1.79
Current Income Taxes Payable	1.59	1.18	2.27	7.07	13.56	15.45
Other Current Liabilities	6.77	7.9	12.73	4.64	2.34	188.61
Total Current Liabilities	116.49	114.03	141.32	105.3	114.06	350.8
Long-Term Debt	42.93	44.02	52.4	9.27	-	5.02
Long-Term Leases	5.07	5.5	5.05	3.42	2.54	4.81
Long-Term Deferred Tax Liabilities	4.51	2.82	4.37	12.37	21.62	27.86
Other Long-Term Liabilities	37.32	32.26	25.85	19.52	15.22	1.7
Total Liabilities	206.32	198.62	228.98	149.87	153.44	390.2
Common Stock	540.13	540.05	599.06	628.85	694.35	723.83
Additional Paid-In Capital	26.5	25.99	23.66	21.78	18.73	16.46
Retained Earnings	146.34	150.89	161.76	191.65	174.55	52.25
Comprensive Income & Other	48.91	29.95	41.38	-0.26	-1.39	18.19
Total Common Equity	761.89	746.87	825.86	842.02	886.24	810.73
Minority Interest	-	-	-	-	-	104.38
Shareholders' Equity	761.89	746.87	825.86	842.02	886.24	915.11
Total Liabilities & Equity	968.21	945.49	1,055	991.89	1,040	1,305
Total Debt	70.09	69.09	77.7	40.96	56.19	62.18
Net Cash (Debt)	129.57	108.18	123.08	119.2	365.18	478.99
Net Cash Growth	17.48%	-12.10%	3.26%	-67.36%	-23.76%	-39.63%
Net Cash Per Share	1.24	1.01	1.07	0.96	2.77	3.42
Filing Date Shares Outstanding	101.38	101.17	110.13	117.03	128.76	135.38
Total Common Shares Outstanding	101.19	101.17	112.21	117.78	130.04	135.64
Working Capital	271.96	251.09	254.3	199.67	438.04	270.72
Book Value Per Share	7.53	7.38	7.36	7.15	6.82	5.98
Tangible Book Value	385.65	377.07	404.8	416.32	651.97	549.1
Tangible Book Value Per Share	3.81	3.73	3.61	3.53	5.01	4.05
Land	-	0.93	1.55	1.09	0.89	0.96
Buildings	-	9.84	14.56	7.69	6.3	6.38
Machinery	-	21.91	33.13	25.94	18.16	15.01

Source: S&P Capital IQ. Standard template.